MicroRNA history: Discovery, recent applications, and next frontiers

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 717, Issue 1-2, 2011, Pages 1-8

  Almeida, Maria I ^a,b   Reis, Rui M ^b,c   Calin, George A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MINHO   (Portugal)

^c BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

Cancer; History; MicroRNAs

Indexed keywords

ADALIMUMAB; ANTAGOMIR; ETANERCEPT; GENE THERAPY AGENT; INFLIXIMAB; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 122; MICRORNA 132; MICRORNA 146; MICRORNA 15; MICRORNA 155; MICRORNA 16; MICRORNA 192; MICRORNA 194; MICRORNA 203; MICRORNA 21; MICRORNA 223; MICRORNA 26A; MICRORNA 346; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BIOGENESIS; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CHRONIC LYMPHATIC LEUKEMIA; DEGENERATIVE DISEASE; DOWN REGULATION; GENE; GENE SILENCING; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HEPATITIS C; HUMAN; LET 7 GENE; LIN 4 GENE; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOLOGICAL MARKERS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICRORNAS; NEOPLASMS;

EID: 82755189644     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.03.009     Document Type: Short Survey

References (113)

1. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9(2):102-114.
2. Ambros V. The functions of animal microRNAs. Nature 2004, 431(7006):350-355.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
4. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
5. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75(5):855-862.
6. Horvitz H.R., Sulston J.E. Isolation and genetic characterization of cell-lineage mutants of the nematode Caenorhabditis elegans. Genetics 1980, 96(2):435-454.
7. Chalfie M., Horvitz H.R., Sulston J.E. Mutations that lead to reiterations in the cell lineages of C. elegans. Cell 1981, 24(1):59-69.
8. Lee R., Feinbaum R., Ambros V. A short history of a short RNA. Cell 2004, 116(2 Suppl.):S89-S92.
9. Ferguson E.L., Sternberg P.W., Horvitz H.R. A genetic pathway for the specification of the vulval cell lineages of Caenorhabditis elegans. Nature 1987, 326(6110):259-267.
10. Ruvkun G., Giusto J. The Caenorhabditis elegans heterochronic gene lin-14 encodes a nuclear protein that forms a temporal developmental switch. Nature 1989, 338(6213):313-319.
11. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403(6772):901-906.
12. Vella M.C., Slack F.J. C. elegans microRNAs. WormBook 2005, 21:1-9.
13. Vella M.C., Choi E.Y., Lin S.Y., Reinert K., Slack F.J. The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3'UTR. Genes Dev. 2004, 18(2):132-137.
14. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., Hayward D.C., Ball E.E., Degnan B., Müller P., Spring J., Srinivasan A., Fishman M., Finnerty J., Corbo J., Levine M., Leahy P., Davidson E., Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408(6808):86-89.
15. Kaufman E.J., Miska E.A. The microRNAs of Caenorhabditis elegans. Semin. Cell Dev. Biol. 2010, 21(7):728-737.
16. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294(5543):853-858.
17. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294(5543):858-862.
18. Lim L.P., Lau N.C., Weinstein E.G., Abdelhakim A., Yekta S., Rhoades M.W., Burge C.B., Bartel D.P. The microRNAs of Caenorhabditis elegans. Genes Dev. 2003, 17(8):991-1008.
19. Abbott A.L., Alvarez-Saavedra E., Miska E.A., Lau N.C., Bartel D.P., Horvitz H.R., Ambros V. The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev. Cell 2005, 9(3):403-414.
20. Peter M.E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8(6):843-852.
21. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36(Database issue):D154-D158.
22. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34(Database issue):D140-D144.
23. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res. 2004, 32(Database issue):D109-D111.
24. Xia W., Cao G., Shao N. Progress in miRNA target prediction and identification. Sci. China C Life Sci. 2009, 52(12):1123-1130.
25. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4(1):44-57.
26. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38(3):323-332.
27. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000, 101(1):25-33.
28. Grishok A., Pasquinelli A.E., Conte D., Li N., Parrish S., Ha I., Baillie D.L., Fire A., Ruvkun G., Mello C.C. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001, 106(1):23-34.
29. Hutvágner G., McLachlan J., Pasquinelli A.E., Bálint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293(5531):834-838.
30. Lund E., Güttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303(5654):95-98.
31. Hwang H.W., Wentzel E.A., Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315(5808):97-100.
32. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466(7308):835-840.
33. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem 2010, 79:351-379.
34. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318(5858):1931-1934.
35. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(5):1608-1613.
36. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5'UTR as in the 3'UTR. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(23):9667-9672.
37. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455(7216):1124-1128.
38. Eiring A.M., Harb J.G., Neviani P., Garton C., Oaks J.J., Spizzo R., Liu S., Schwind S., Santhanam R., Hickey C.J., Becker H., Chandler J.C., Andino R., Cortes J., Hokland P., Huettner C.S., Bhatia R., Roy D.C., Liebhaber S.A., Caligiuri M.A., Marcucci G., Garzon R., Croce C.M., Calin G.A., Perrotti D. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010, 140(5):652-665.
39. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(24):15524-15529.
40. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(9):2999-3004.
41. Li C., Feng Y., Coukos G., Zhang L. Therapeutic microRNA strategies in human cancer. AAPS J. 2009, 11(4):747-757.
42. Garzon R., Calin G.A., Croce C.M. MicroRNAs in Cancer. Annu. Rev. Med. 2009, 60:167-179.
43. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120(5):635-647.
44. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(39):13944-13949.
45. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(7043):828-833.
46. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. C-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435(7043):839-843.
47. He L., He X., Lowe S.W., Hannon G.J. MicroRNAs join the p53 network - another piece in the tumor-suppression puzzle. Nat. Rev. Cancer 2007, 7(11):819-822.
48. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467(7311):86-90.
49. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., Jones P.A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9(6):435-443.
50. Chuang J.C., Jones P.A. Epigenetics and microRNAs. Pediatr. Res. 2007, 61(5 Pt. 2):24R-29R.
51. Bao N., Lye K.W., Barton M.K. MicroRNA binding sites in Arabidopsis class III HD-ZIP mRNAs are required for methylation of the template chromosome. Dev. Cell 2004, 7(5):653-662.
52. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S., Calin G.A. MicroRNAs - the micro steering wheel of tumour metastases. Nat. Rev. Cancer 2009, 9(4):293-302.
53. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449(7163):682-688.
54. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Puré E., Agami R. The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nat. Cell Biol. 2008, 10(2):202-210.
55. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451(7175):147-152.
56. Lujambio A., Calin G.A., Villanueva A., Ropero S., Sánchez-Céspedes M., Blanco D., Montuenga L.M., Rossi S., Nicoloso M.S., Faller W.J., Gallagher W.M., Eccles S.A., Croce C.M., Esteller M. A microRNA DNA methylation signature for human cancer metastases. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(36):13556-13561.
57. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436(7048):214-220.
58. Kwon C., Han Z., Olson E.N., Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(52):18986-18991.
59. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38(2):228-233.
60. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(48):18255-18260.
61. Edwards J.K., Pasqualini R., Arap W., Calin G.A. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J. Cardiovasc. Transl. Res. 2010, 3(3):271-279.
62. Jazbutyte V., Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr. Drug Targets 2010, 11(8):926-935.
63. Cheng Y., Ji R., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am. J. Pathol. 2007, 170(6):1831-1840.
64. Sonkoly E., Wei T., Janson P.C., Sääf A., Lundeberg L., Tengvall-Linder M., Norstedt G., Alenius H., Homey B., Scheynius A., Ståhle M., Pivarcsi A. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS One 2007, 2(7):e610.
65. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Förster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., Alexander W.S. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4(6):540-545.
66. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., Itami S., Nickoloff B.J., DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 2005, 11(1):43-49.
67. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N. Engl. J. Med. 2009, 361(5):496-509.
68. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(33):12481-12486.
69. Sivamani R.K., Correa G., Ono Y., Bowen M.P., Raychaudhuri S.P., Maverakis E. Biological therapy of psoriasis. Indian J. Dermatol. 2010, 55(2):161-170.
70. Sonkoly E., Ståhle M., Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin. Cancer Biol. 2008, 18(2):131-140.
71. Smolen J.S., Aletaha D., Koeller M., Weisman M.H., Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007, 370(9602):1861-1874.
72. Stanczyk J., Pedrioli D.M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R.E., Detmar M., Gay S., Kyburz D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008, 58(4):1001-1009.
73. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., Asahara H. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008, 58(5):1284-1292.
74. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 2008, 10(4):R101.
75. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009, 32(3-4):189-194.
76. Alsaleh G., Suffert G., Semaan N., Juncker T., Frenzel L., Gottenberg J.E., Sibilia J., Pfeffer S., Wachsmann D. Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J. Immunol. 2009, 182(8):5088-5097.
77. Fulci V., Scappucci G., Sebastiani G.D., Giannitti C., Franceschini D., Meloni F., Colombo T., Citarella F., Barnaba V., Minisola G., Galeazzi M., Macino G. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum. Immunol. 2010, 71(2):206-211.
78. Joseph A., Brasington R., Kahl L., Ranganathan P., Cheng T.P., Atkinson J. Immunologic rheumatic disorders. J. Allergy Clin. Immunol. 2010, 125(2 Suppl. 2):S204-S215.
79. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., Xu Z.M., Yin Y.B. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16(12):939-946.
80. Pan W., Zhu S., Yuan M., Cui H., Wang L., Luo X., Li J., Zhou H., Tang Y., Shen N. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 2010, 184(June (12)):6773-6781.
81. Te J.L., Dozmorov I.M., Guthridge J.M., Nguyen K.L., Cavett J.W., Kelly J.A., Bruner G.R., Harley J.B., Ojwang J.O. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010, 5(5):e10344.
82. Zhao X., Tang Y., Qu B., Cui H., Wang S., Wang L., Luo X., Huang X., Li J., Chen S., Shen N. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010, (Epub ahead of print).
83. Dai Y., Sui W., Lan H., Yan Q., Huang H., Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int. 2009, 29(7):749-754.
84. Fiore R., Siegel G., Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim. Biophys. Acta 2008, 1779(8):471-478.
85. Christensen M., Schratt G.M. microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci. Lett. 2009, 466(2):55-62.
86. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 2007, 204(7):1553-1558.
87. Nelson P.T., Wang W.X., Rajeev B.W. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol. 2008, 18(1):130-138.
88. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18(3):297-300.
89. Hugon J., Paquet C. Targeting miRNAs in Alzheimer's disease. Expert Rev. Neurother. 2008, 8(11):1615-1616.
90. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317(5842):1220-1224.
91. Hébert S.S., De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009, 32(4):199-206.
92. Barbato C., Ruberti F., Cogoni C. Searching for MIND: microRNAs in neurodegenerative diseases. J. Biomed. Biotechnol. 2009, 2009:871313.
93. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., Mitsudomi T., Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64(11):3753-3756.
94. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005, 353(17):1793-1801.
95. Wittmann J., Jäck H.M. Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta 2010, (Epub ahead of print).
96. Cortez M.A., Calin G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 2009, 9(6):703-711.
97. Chim S.S., Shing T.K., Hung E.C., Leung T.Y., Lau T.K., Chiu R.W., Lo Y.M. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 2008, 54(3):482-490.
98. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S., Hatton C.S., Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141(5):672-675.
99. Murata K., Yoshitomi H., Tanida S., Ishikawa M., Nishitani K., Ito H., Nakamura T. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther. 2010, 12(3):R86.
100. Buckland J. Biomarkers: microRNAs under the spotlight in inflammatory arthritis. Nat. Rev. Rheumatol. 2010, 6(8):436.
101. Rossbach M. Small non-coding RNAs as novel therapeutics. Curr. Mol. Med. 2010, 10(4):361-368.
102. van Rooij E., Marshall W.S., Olson E.N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res. 2008, 103(9):919-928.
103. Hutvágner G., Simard M.J., Mello C.C., Zamore P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004, 2(4):E98.
104. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438(7068):685-689.
105. Krützfeldt J., Kuwajima S., Braich R., Rajeev K.G., Pena J., Tuschl T., Manoharan M., Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 2007, 35(9):2885-2892.
106. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjärn M., Hansen H.F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E.M., Kauppinen S. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452(7189):896-899.
107. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., Kauppinen S., Ørum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327(5962):198-201.
108. Soifer H.S., Rossi J.J., Saetrom P. MicroRNAs in disease and potential therapeutic applications. Mol. Ther. 2007, 15(12):2070-2079.
109. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441(7092):537-541.
110. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., Chang T.C., Vivekanandan P., Torbenson M., Clark K.R., Mendell J.R., Mendell J.T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137(6):1005-1017.
111. Calin G.A., Liu C.G., Ferracin M., Hyslop T., Spizzo R., Sevignani C., Fabbri M., Cimmino A., Lee E.J., Wojcik S.E., Shimizu M., Tili E., Rossi S., Taccioli C., Pichiorri F., Liu X., Zupo S., Herlea V., Gramantieri L., Lanza G., Alder H., Rassenti L., Volinia S., Schmittgen T.D., Kipps T.J., Negrini M., Croce C.M. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007, 12(3):215-229.
112. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464(7291):1071-1076.
113. Mattick J.S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001, 2(11):986-991.